Home -
Products -
Others -
Other Targets -
2-(2,6-dioxopiperidin-3-yl)-4-((7-hydroxyheptyl)oxy)isoindoline-1,3-dione
2-(2,6-dioxopiperidin-3-yl)-4-((7-hydroxyheptyl)oxy)isoindoline-1,3-dione
CAS No. 2093536-10-6
2-(2,6-dioxopiperidin-3-yl)-4-((7-hydroxyheptyl)oxy)isoindoline-1,3-dione ( —— )
Catalog No. M28650 CAS No. 2093536-10-6
2-(2,6-dioxopiperidin-3-yl)-4-((7-hydrox is protac.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 302 | Get Quote |
|
10MG | 447 | Get Quote |
|
25MG | 714 | Get Quote |
|
50MG | 1017 | Get Quote |
|
100MG | 1368 | Get Quote |
|
500MG | 2673 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name2-(2,6-dioxopiperidin-3-yl)-4-((7-hydroxyheptyl)oxy)isoindoline-1,3-dione
-
NoteResearch use only, not for human use.
-
Brief Description2-(2,6-dioxopiperidin-3-yl)-4-((7-hydrox is protac.
-
Description2-(2,6-dioxopiperidin-3-yl)-4-((7-hydrox is protac.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPDE4;TNF-α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2093536-10-6
-
Formula Weight388.4
-
Molecular FormulaC20H24N2O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOCCCCCCCOc1cccc(C(N2C(CCC(N3)=O)C3=O)=O)c1C2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Man HW, et al. Discovery of (S)-N-[2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl] acetamide (apremilast), a potent and orally active phosphodiesterase 4and tumor necrosis factor-alpha inhibitor. J Med Chem. 2009 Mar 26;52(6):1522-4.
molnova catalog
related products
-
Arjunetin
Arjunetin, an insect feeding-deterrent and growth inhibitor, shows antioxidant and anti-inflammatory activities.
-
TPT-260
TPT-260 2hydrochloride (TPU260 2hydrochloride) is a thiophene thiourea derivative with molecule weight 260.00 in free base form.
-
WRW4 TFA(878557-55-2...
Selective antagonist of formyl peptide receptor 2 (FPR2) signaling. Inhibits WKYMVm binding to FPR2 (IC50 = 0.23 μM) and inhibits intracellular calcium release induced by WKYMVm, MMK 1, amyloid β42, and F peptide. Also inhibits FPR2-mediated signaling in human neutrophils; blocks chemotactic migration and superoxide generation by amyloid β42 peptide.